Biotech Research- Combating the 2026 Bundibugyo Outbreak: How IBT Bioservices Accelerates Vaccine and Therapeutic Development
- Accelerating Flavivirus Therapeutics: Validated Assays from Discovery to Dose
- Unmatched Precision: IBT’s Advanced ELISA Testing Capabilities to Support Clinical & Preclinical Development for Vaccines and Therapeutics
- Decoding the Immune Symphony: Why Luminex Cytokine Analysis is Essential for Preclinical Vaccine and Therapeutic Development
- Combat S. aureus: Essential Products to Study Staphylococcal Infections
- Finding the right CRO for grants
- Staphylococcus aureus bacteremia Non-Human Primate model
- Your Ultimate Guide: Our Upgraded Webstore’s New Features Make Shopping Easy!
- Paving the Way for Next-Gen Universal Flu Vaccines: Why HAI Assays Are Essential
- Unlocking the Future of Infectious Disease Research:
Monthly Archives: December 2024
VEGI (Vascular Endothelial Growth Inhibitor) (VEGI/1283), CF488A Conjugate, 0.1 mg/mL Antibody
The VEGI/1283 Antibody conjugated with CF488A, a bright green fluorescent dye, is specifically designed for detecting Vascular Endothelial Growth Inhibitor (VEGI). VEGI, a member of the tumor necrosis factor (TNF) superfamily, plays a critical role in regulating vascular endothelial cell … Continue reading
Posted in Blogging
Comments Off on VEGI (Vascular Endothelial Growth Inhibitor) (VEGI/1283), CF488A Conjugate, 0.1 mg/mL Antibody